Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Policy makers and consumers are increasingly concerned about the quality and efficiency of care provided to individuals with severe, chronic illnesses such as schizophrenia. These illnesses are expensive to treat and present significant challenges to organizations that are responsible for providing effective care. Occurring in 1% of the United States population, schizophrenia accounts for 10% of permanently disabled people, and 2.5% of all healthcare expenditures. Clinical practice guidelines have been promulgated. Schizophrenia is treatable and outcomes can be substantially improved with the appropriate use of antipsychotic medication, caregiver education and counseling, vocational rehabilitation, and assertive treatment. However, in the VA and other mental health systems, many patients with schizophrenia receive substandard care. Methods are needed that improve the quality of usual care for this disorder while being feasible to implement at typical clinics.
To date, most efforts to improve care for schizophrenia have focused on educating clinicians or changing the financing of care, and have had limited success. We believe a more fundamental approach should be tried. While there are many potential strategies, experience in chronic medical illness and mental health support the efficacy of specific approaches. Collaborative care models are one such approach. They are a blueprint for reorganizing practice, and involve changes in division of labor and responsibility, adoption of new care protocols, and increased attention to patients' needs. Although collaborative care models have been successful in other chronic medical conditions, they have not yet been studied in the treatment of schizophrenia.
We have developed a collaborative care model for schizophrenia that builds on work in other disorders, and includes service delivery approaches that are known to be effective in schizophrenia. The model focuses on improving treatment through assertive care management, caregiver education and support, and standardized patient assessment with feedback of information to psychiatrists. This project, "EQUIP" (Enhancing Quality Utilization In Psychosis) is implementing collaborative care and evaluating its effectiveness in schizophrenia.
| Condition | Intervention |
|---|---|
|
Schizophrenia Disorders Chronic Illness Schizoaffective Disorder Weight Gain |
Procedure: Collaborative Chronic Illness Model |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Factorial Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP) |
- At 15 mo.: Provider attitudes on controlling symptoms & side-effects, & on family involvement Patient clinical outcomes Throughout the study: Patient compliance Provider practice patterns & adherence to VA guidelines Patient utilization [ Designated as safety issue: No ]
- Process assessment throughout the course of the study of barriers and facilitators to the intervention�s implementation [ Designated as safety issue: No ]
| Estimated Enrollment: | 443 |
| Study Start Date: | January 2002 |
| Study Completion Date: | December 2004 |
| Arms | Assigned Interventions |
|---|---|
| Arm 1 | Procedure: Collaborative Chronic Illness Model |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Providers (Psychiatrists, Case Managers, Nurses):
Working at one of the participating VA Mental Health Clinics
Providers: 68 Patients: 375
Patients:
- At least 18 years old
- Diagnosis of Schizophrenia, Schizoaffective, or schizophreniform disorder
- At least 2 treatment visits with a psychiatrist at the clinic during the previous 6 months.
Exclusion Criteria:
None
Contacts and Locations| United States, California | |
| VA Greater Los Angeles Health Care System | |
| West Los Angeles, California, United States, 90073 | |
| Principal Investigator: | Alexander S. Young, MD MSHS | VA Greater Los Angeles Health Care System |
More Information
Additional Information:
Publications:
| Responsible Party: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00119574 History of Changes |
| Other Study ID Numbers: | CPI 99-383, RCD 00-033, NIMH MH-5423, NIMH MH-068639 |
| Study First Received: | July 1, 2005 |
| Last Updated: | August 1, 2012 |
| Health Authority: | United States: Federal Government |
Keywords provided by Department of Veterans Affairs:
|
Randomized Controlled Trial Quality of Health Care Health Services Research Guidelines Medical Informatics Computing |
Services, Mental Health Medicine, Evidence-Based Quality Assurance, Healthcare Quality Indicators, Health Care Veterans |
Additional relevant MeSH terms:
|
Chronic Disease Psychotic Disorders Schizophrenia Weight Gain Disease Attributes Pathologic Processes |
Schizophrenia and Disorders with Psychotic Features Mental Disorders Body Weight Changes Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on May 22, 2013